Skip to main content
Have a personal or library account? Click to login
Valproate and EEG Abnormalities Cover
Open Access
|Dec 1992

Full Article

The effect of valproate on EEG epileptic abnormalities was investigated at the Institute of Neurophysiology, Genoa, Italy. Sixteen patients aged 14 to 44 years were administered a single (14-37 mg/kg) oral dose of magnesium valproate. At peak serum concentrations of 65-139 ug/ml of valproate, there were increases in spike wave frequency at 2, 3, 4 and 5 hours. The peak concentrations of ammonia ranged from 15-72 ug/1, with values exceeding normal in 13 determinations. The VPA and ammonia concentrations varied independently. The frequency of EEG epileptic abnormalities was not correlated with either the ammonemia level or the amount of variation in ammonemia concentration. [1]

COMMENT. A direct CNS drug action has been proposed to explain the quantitative EEG abnormalities in response to acute VPA administration and the stupor states in some patients. The stupor was not necessarily related to the increased ammonia concentration in the blood.

Language: English
Page range: 93 - 93
Published on: Dec 1, 1992
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services

© 1992 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.